BTX品牌介绍
品牌简介
布鲁克林免疫治疗公司（BTX）是一家临床阶段的生物制药公司，致力于创造一个世界，让医疗需求高度未得到满足的患者和家庭能够获得有效治疗。
我们是使用最新技术的先驱，如合成mRNA、细胞重编程、基因编辑和复杂的人类衍生混合细胞因子。这些进步推动了我们正在进行的项目，包括iPSC衍生的MSC（iMSC）、基因编辑的iMSC和体内基因编辑。此外，我们还开发了IRX-2免疫疗法，该疗法已接近2b期研究的结论。
Brooklyn ImmunoTherapeutics (BTX) is a clinical-stage biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments.
We are pioneers in using the latest technologies such as synthetic mRNA, cellular reprogramming, gene editing, and complex human-derived mixed cytokines. These advances fuel our ongoing programs, including iPSC-derived MSC (iMSC), gene-edited iMSC, and in vivo gene editing. Additionally, we have developed the IRX-2 immuno-therapy, which is approaching the conclusion of its Phase2B study.
main products
cell engineering and complex cytokines.
https://www.brooklynitx.com
联系我们
